RESUMEN
OBJECTIVE: Autoantibodies against antigens carrying distinct post-translational modifications (PTMs), such as citrulline, homocitrulline or acetyllysine, are hallmarks of rheumatoid arthritis (RA). The relation between these anti-modified protein antibody (AMPA)-classes is poorly understood as is the ability of different PTM-antigens to activate B-cell receptors (BCRs) directed against citrullinated proteins (CP). Insights into the nature of PTMs able to activate such B cells are pivotal to understand the 'evolution' of the autoimmune response conceivable underlying the disease. Here, we investigated the cross-reactivity of monoclonal AMPA and the ability of different types of PTM-antigens to activate CP-reactive BCRs. METHODS: BCR sequences from B cells isolated using citrullinated or acetylated antigens were used to produce monoclonal antibodies (mAb) followed by a detailed analysis of their cross-reactivity towards PTM-antigens. Ramos B-cell transfectants expressing CP-reactive IgG BCRs were generated and their activation on stimulation with PTM-antigens investigated. RESULTS: Most mAbs were highly cross-reactive towards multiple PTMs, while no reactivity was observed to the unmodified controls. B cells carrying CP-reactive BCRs showed activation on stimulation with various types of PTM-antigens. CONCLUSIONS: Our study illustrates that AMPA exhibit a high cross-reactivity towards at least two PTMs indicating that their recognition pattern is not confined to one type of modification. Furthermore, our data show that CP-reactive B cells are not only activated by citrullinated, but also by carbamylated and/or acetylated antigens. These data are vital for the understanding of the breach of B-cell tolerance against PTM-antigens and the possible contribution of these antigens to RA-pathogenesis.
Asunto(s)
Anticuerpos Antiproteína Citrulinada/inmunología , Artritis Reumatoide/inmunología , Linfocitos B/inmunología , Procesamiento Proteico-Postraduccional/inmunología , Receptores de Antígenos de Linfocitos B/inmunología , Acetilación , Anciano , Autoanticuerpos/inmunología , Citrulinación/inmunología , Citrulina/análogos & derivados , Citrulina/inmunología , Reacciones Cruzadas/inmunología , Femenino , Humanos , Inmunoglobulina G , Masculino , Persona de Mediana Edad , Carbamilación de Proteína/inmunologíaRESUMEN
The non-receptor protein tyrosine kinase Syk (spleen tyrosine kinase) is an important mediator of signal transduction in B cells. By acting downstream of the B-cell antigen receptor, Syk promotes signaling pathways involved in proliferation, differentiation and survival of B cells. To study the oncogenic potential of Syk, we generated a mouse model for the inducible expression of the leukemia-derived TEL-Syk fusion protein exhibiting constitutive kinase activity. To achieve B-cell-specific expression of TEL-Syk in adult mice, we used a tamoxifen-inducible Cre mouse line. This study shows that inducible expression of TEL-Syk in B cells leads to transient proliferation and subsequent plasma cell differentiation. However, it does not lead to B-cell transformation. Instead, Syk activation induces the tumor suppressor B-lymphocyte-induced maturation protein-1 (Blimp-1), which interferes with the expression of the antiapoptotic protein Bcl-2. Combined induction of TEL-Syk with transgenic expression of Bcl-2 results in a severe phenotype and plasma cell expansion. Our results suggest that deregulated Syk activity by itself is not sufficient for the transformation of B cells, as downstream effectors, such as Blimp-1, limit the survival and expansion of the activated B cell.
Asunto(s)
Linfocitos B/citología , Diferenciación Celular , Péptidos y Proteínas de Señalización Intracelular/genética , Proteínas Tirosina Quinasas/genética , Factores de Transcripción/metabolismo , Animales , Apoptosis , Linfocitos B/metabolismo , Biomarcadores/metabolismo , Supervivencia Celular , Expresión Génica/efectos de los fármacos , Integrasas/metabolismo , Ratones , Ratones Transgénicos , Mutación , Fenotipo , Células Plasmáticas/citología , Factor 1 de Unión al Dominio 1 de Regulación Positiva , Proteínas Recombinantes de Fusión/genética , Quinasa Syk , Tamoxifeno/farmacologíaRESUMEN
Inactivating Tp53 mutations are frequent genetic lesions in human tumors that harbor genomic instability, including B lineage lymphomas with IG translocations. Antigen receptor genes are assembled and modified in developing lymphocytes by RAG/AID-initiated genomic rearrangements that involve the induction of DNA double strand breaks (DSBs). Although TP53 inhibits the persistence of DSBs and induces apoptosis to protect cells from genomic instability and transformation, the development of spontaneous tumors harboring clonal translocations has not been reported in mice that only lack wild-type Tp53 protein or express Tp53 mutants. Tp53-deficient (Tp53(-/-)) mice succumb to T lineage lymphomas lacking clonal translocations but develop B lymphoid tumors containing immunoglobulin (Ig) translocations upon combined inactivation of DSB repair factors, RAG mutation or AID overexpression; mice expressing apoptosis-defective Tp53 mutants develop B cell lymphomas that have not been characterized for potential genomic instability. As somatic rather than germline inactivating mutations of TP53 are typically associated with human cancers and Tp53 deletion has cellular context dependent effects upon lymphocyte transformation, we generated mice with conditional Tp53 deletion in lineage-committed B lymphocytes to avoid complications associated with defective Tp53 responses during embryogenesis and/or in multi-lineage potential cells and, thereby, directly evaluate the potential physiological role of Tp53 in suppressing translocations in differentiated cells. These mb1-cre:Tp53(flox/flox) mice succumbed to lymphoid tumors containing Ig gene rearrangements and immunophenotypes characteristic of B cells from various developmental stages. Most mb1-cre:Tp53(flox/flox) tumors harbored clonal translocations, including Igh/c-myc or other oncogenic translocations generated by the aberrant repair of RAG/AID-generated DSBs. Our data indicate that Tp53 serves critical functions in B lineage lymphocytes to prevent transformation caused by translocations in cell populations experiencing physiological levels of RAG/AID-initiated DSB intermediates, and provide evidence that the somatic TP53 mutations found in diffuse large B-cell lymphoma and Burkitt's lymphoma may contribute to the development of these human malignancies.
Asunto(s)
Linfocitos B/inmunología , Linaje de la Célula , Linfoma de Células B/etiología , Translocación Genética , Proteína p53 Supresora de Tumor/fisiología , Animales , Linfoma de Burkitt/etiología , Roturas del ADN de Doble Cadena , Reparación del ADN por Unión de Extremidades , Femenino , Genes de Inmunoglobulinas , Genes myc , Cadenas Pesadas de Inmunoglobulina/genética , Linfoma de Células B/genética , Masculino , RatonesRESUMEN
The mb1 gene encodes the Ig-alpha signaling subunit of the B cell antigen receptor and is expressed exclusively in B cells beginning at the very early pro-B cell stage in the bone marrow. We examine here the efficacy of the mb1 gene as a host locus for cre recombinase expression in B cells. We show that by integrating a humanized cre recombinase into the mb1 locus we obtain extraordinarily efficient recombination of loxP sites in the B cell lineage. The results from a variety of reporter genes including the splicing factor SRp20 and the DNA methylase Dnmt1 suggest that mb1-cre is probably the best model so far described for pan-B cell-specific cre expression. The availability of a mouse line with efficient cre-mediated recombination at an early developmental stage in the B lineage provides an opportunity to study the role of various genes specifically in B cell development and function.
Asunto(s)
Linfocitos B/fisiología , Antígenos CD79/genética , Marcación de Gen , Integrasas/metabolismo , Ratones Mutantes/genética , Animales , Antígenos CD19/genética , Linfocitos B/citología , Linfocitos B/efectos de los fármacos , Linaje de la Célula , ADN (Citosina-5-)-Metiltransferasa 1 , ADN (Citosina-5-)-Metiltransferasas/genética , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Eliminación de Gen , Expresión Génica , Genes Reporteros , Integrasas/genética , Interleucina-7/farmacología , Ratones , Proteínas de Unión al ARN/genética , Proteínas de Unión al ARN/metabolismo , Recombinación Genética , Factores de Empalme Serina-ArgininaRESUMEN
The BRAF(V600E) mutation is found in approximately 6% of human cancers and mimics the phosphorylation of the kinase domain activation segment. In wild-type B-Raf (B-Raf(wt)), activation segment phosphorylation is thought to cooperate with negative charges within the N-region for full activation. In contrast to Raf-1, the N-region of B-Raf is constitutively negatively charged owing to the presence of residues D447/D448 and the phosphorylation of S446. Therefore, it has been suggested that this hallmark predisposes B-Raf for oncogenic activation. In this study, we demonstrate that neutralizing mutations of these residues (in particular S446 and S447), or uncoupling of B-Raf from Ras-guanine 5'-triphosphate (GTP), strongly reduce the biological activity of B-Raf in a PC12 cell differentiation assay. We also confirm that S365 is a 14-3-3 binding site, and determine that mutation of this residue rescues the impaired biological activity of B-Raf proteins with a neutralized N-region, suggesting that the N-region opposes a 14-3-3-mediated transition into an inactive conformation. However, in the case of B-Raf(V600E), although complete N-region neutralization resulted in a 2.5-fold reduction in kinase activity in vitro, this oncoprotein strongly induced PC12 differentiation or transformation and epithelial-mesenchymal transition of MCF-10A cells regardless of its N-region charge. Furthermore, the biological activity of B-Raf(V600E) was independent of its ability to bind Ras-GTP. Our analysis identifies important regulatory differences between B-Raf(wt) and B-Raf(V600E) and suggests that B-Raf(V600E) cannot be inhibited by strategies aimed at blocking S446 phosphorylation or Ras activation.
Asunto(s)
Sustitución de Aminoácidos , Mutación Missense , Mutación Puntual , Proteínas Proto-Oncogénicas B-raf/fisiología , Proteínas 14-3-3/metabolismo , Animales , Sitios de Unión , Diferenciación Celular , Línea Celular/citología , Línea Celular/metabolismo , Transformación Celular Neoplásica , Pollos , Activación Enzimática , Células Epiteliales/citología , Retroalimentación Fisiológica , Guanosina Trifosfato/metabolismo , Humanos , Sistema de Señalización de MAP Quinasas , Mesodermo/citología , Ratones , Modelos Biológicos , Células 3T3 NIH , Proteína Oncogénica p21(ras)/metabolismo , Células PC12 , Fosforilación , Mapeo de Interacción de Proteínas , Procesamiento Proteico-Postraduccional , Estructura Terciaria de Proteína , Proteínas Proto-Oncogénicas B-raf/antagonistas & inhibidores , Proteínas Proto-Oncogénicas B-raf/química , Proteínas Proto-Oncogénicas B-raf/genética , Ratas , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/fisiología , Relación Estructura-Actividad , TransfecciónRESUMEN
Yeast Rad52 DNA-repair mutants exhibit pronounced radiation sensitivity and a defect in homologous re combination (HR), whereas vertebrate cells lacking Rad52 exhibit a nearly normal phenotype. Bio chemical studies show that both yeast Rad52 and Rad55-57 (Rad51 paralogs) stimulate DNA-strand exchange mediated by Rad51. These findings raise the possibility that Rad51 paralogs may compensate for lack of Rad52 in vertebrate cells, explaining the absence of prominent phenotypes for Rad52-deficient cells. To test this hypothesis, using chicken DT40 cells, we generated conditional mutants deficient in both RAD52 and XRCC3, which is one of the five vertebrate RAD51 paralogs. Surprisingly, the rad52 xrcc3 double-mutant cells were non-viable and exhibited extensive chromosomal breaks, whereas rad52 and xrcc3 single mutants grew well. Our data reveal an overlapping (but non-reciprocal) role for Rad52 and XRCC3 in repairing DNA double-strand breaks. The present study shows that Rad52 can play an important role in HR repair by partially substituting for a Rad51 paralog.
Asunto(s)
Cromosomas/genética , Reparación del ADN , Proteínas de Unión al ADN/metabolismo , Animales , Proteínas Aviares , Evolución Biológica , Proteínas de Unión al ADN/genética , Genes Letales , Humanos , Recombinasa Rad51 , Recombinación GenéticaRESUMEN
Mice deficient for the adapter protein SLP65 (BLNK) show a partial block in early B cell development, reduced numbers of mature B cells in the periphery, an absence of B1 cells and a reduction of IgM and IgG3 serum immunoglobulin levels. A strikingly similar phenotype is observed in Btk-deficient mice. To investigate the consequences of mutations in both SLP65 and Btk, we generated SLP65/ Btk double-mutant mice by crossing the single-mutant mice. Analysis of the double-mutant mice reveals a much more severe defect in B cell development. B cells in the SLP65/Btk double-mutant mice are arrested at the preB cell stage and, surprisingly, express the preB cell receptor. Normally, preB cell receptor expression in wild-type mice is restricted to a very small fraction of B cells making it difficult to identify these cells in the bone marrow. Together, the data demonstrate the synergistic role of SLP65 and Btk in B cell development and describe a situation where large numbers of preB cell receptor-positive cells accumulate in the bone marrow and spleen.
Asunto(s)
Antígenos CD , Linfocitos B/inmunología , Proteínas Portadoras/genética , Proteínas Portadoras/fisiología , Fosfoproteínas/genética , Fosfoproteínas/fisiología , Proteínas Tirosina Quinasas/genética , Proteínas Tirosina Quinasas/fisiología , Receptores de Antígenos de Linfocitos B/análisis , Proteínas Adaptadoras Transductoras de Señales , Agammaglobulinemia Tirosina Quinasa , Animales , Médula Ósea/inmunología , Diferenciación Celular , Eliminación de Gen , Leucosialina , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Sialoglicoproteínas/análisis , Bazo/inmunología , Células Madre/inmunologíaRESUMEN
Antigen receptors on lymphocytes utilize different signaling modes to control the positive and negative selection of lymphocytes. In addition, these receptors have to detect the amount and affinity of the antigen and set delicate threshold values for the activation of lymphocytes. It is suggested that the antigen receptors on B and T-cells form oligomeric complexes, inside of which, signals can be processed and amplified in a manner that might explain the different signaling outputs of these receptors.
Asunto(s)
Linfocitos/inmunología , Receptores de Antígenos de Linfocitos B/inmunología , Receptores de Antígenos de Linfocitos T/inmunología , Transducción de Señal/inmunología , Animales , Humanos , Modelos InmunológicosRESUMEN
Signaling through the B cell antigen receptor (BCR) is negatively regulated by the SH2 domain-containing protein-tyrosine phosphatase SHP-1, which requires association with tyrosine-phosphorylated proteins for activation. Upon BCR ligation, SHP-1 has been shown to associate with the BCR, the cytoplasmic protein-tyrosine kinases Lyn and Syk, and the inhibitory co-receptors CD22 and CD72. How SHP-1 is activated by BCR ligation and regulates BCR signaling is, however, not fully understood. Here we demonstrate that, in the BCR-expressing myeloma line J558L mu 3, CD72 expression reduces the BCR ligation-induced phosphorylation of the BCR component Ig alpha/Ig beta and its cytoplasmic effectors Syk and SLP-65. Substrate phosphorylation was restored by expression of dominant negative mutants of SHP-1, whereas the SHP-1 mutants failed to enhance phosphorylation of the cellular substrates in the absence of CD72. This indicates that SHP-1 is efficiently activated by CD72 but not by other pathways in J558L mu m3 cells and that inhibition of SHP-1 specifically activated by CD72 reverses CD72-induced dephosphorylation of cellular substrates in these cells. Taken together, BCR-induced SHP-1 activation is likely to require inhibitory co-receptors such as CD72, and SHP-1 appears to mediate the negative regulatory effect of CD72 on BCR signaling by dephosphorylating Ig alpha/Ig beta and its downstream signaling molecules Syk and SLP-65.
Asunto(s)
Linfocitos B/metabolismo , Proteínas Tirosina Fosfatasas/metabolismo , Receptores de Antígenos de Linfocitos B/metabolismo , Regulación hacia Abajo , Humanos , Péptidos y Proteínas de Señalización Intracelular , Fosforilación , Proteína Tirosina Fosfatasa no Receptora Tipo 6 , Transducción de Señal , Especificidad por Sustrato , Células Tumorales CultivadasRESUMEN
Expression of the cystic fibrosis transmembrane conductance regulator (CFTR) is stringently controlled by molecular chaperones participating in formation of the quality control system. It has been shown that about 75% of all CFTR protein and close to 100% of the [DeltaPhe(508)] CFTR variant are rapidly degraded before leaving the endoplasmic reticulum (ER). B cell antigen receptor-associated proteins (BAPs) are ubiquitously expressed integral membrane proteins that may control association with the cytoskeleton, vesicular transport, or retrograde transport from the cis Golgi to the ER. The present study delivers evidence for cytosolic co-localization of both BAP31 and CFTR and for the control of expression of recombinant CFTR in Chinese hamster ovary (CHO) cells and Xenopus oocytes by BAP31. Antisense inhibition of BAP31 in various cell types increased expression of both wild-type CFTR and [DeltaPhe(508)]CFTR and enabled cAMP-activated Cl(-) currents in [DeltaPhe(508)]CFTR-expressing CHO cells. Coexpression of CFTR together with BAP31 attenuated cAMP-activated Cl(-) currents in Xenopus oocytes. These data therefore suggest association of BAP31 with CFTR that may control maturation or trafficking of CFTR and thus expression in the plasma membrane.
Asunto(s)
Regulador de Conductancia de Transmembrana de Fibrosis Quística/genética , Regulación de la Expresión Génica/fisiología , Proteínas de la Membrana , Proteínas/fisiología , Animales , Células CHO , Canales de Cloruro/fisiología , Cloruros/metabolismo , Cricetinae , Transporte Iónico , XenopusRESUMEN
The B cell antigen receptor (BCR) plays a central role in the development, survival and activation of B lymphocytes. As the pre-BCR, it controls allelic exclusion of heavy chains and the expansion of pre-B cells. As the BCR, it controls the positive and negative selection of immature B cells as well as the survival and activation of mature B cells. Recent studies of receptors have shown that it is the ligand that brings them into the conformation necessary for signaling. How the multiple and structurally diverse antigens could fulfill this task for the BCR is unknown, and we regard this as an unsolved problem of Burnet's clonal selection theory This question and our recent biochemical studies lead us to propose a new model for the BCR, according to which the BCR exists as a precise oligomeric complex on the B cell surface. In this form, it can signal positive selection and survival of B cells. Binding to self- or foreign antigen results in a distortion of the oligomeric complex that gives the signal for negative selection of immature and activation of mature B cells.
Asunto(s)
Modelos Biológicos , Receptores de Antígenos de Linfocitos B/química , Animales , Linfocitos B/inmunología , Supresión Clonal , Humanos , Modelos Moleculares , Estructura Cuaternaria de Proteína , Transducción de SeñalRESUMEN
Notch receptors play various roles for cell fate decisions in developing organs, although their functions at the cell level are poorly understood. Recently, we found that Notch1 and its ligand are each expressed in juxtaposed cell compartments in the follicles of the bursa of Fabricius, the central organ for chicken B cell development. To examine the function of Notch1 in B cells, a constitutively active form of chicken Notch1 was expressed in a chicken B cell line, DT40, by a Cre/loxP-mediated inducible expression system. Remarkably, the active Notch1 caused growth suppression of the cells, accompanied by a cell cycle inhibition at the G(1) phase and apoptosis. The expression of Hairy1, a gene product up-regulated by the Notch1 signaling, also induced the apoptosis, but no cell cycle inhibition. Thus, Notch1 signaling induces apoptosis of the B cells through Hairy1, and the G(1) cell cycle arrest through other pathways. This novel function of Notch1 may account for the recent observations indicating the selective inhibition of early B cell development in mice by Notch1.
Asunto(s)
Apoptosis , Proteínas Aviares , Linfocitos B/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Proteínas de la Membrana/farmacología , Receptores de Superficie Celular , Factores de Transcripción , Animales , Apoptosis/efectos de los fármacos , Linfocitos B/fisiología , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico , Relojes Biológicos , División Celular/efectos de los fármacos , Pollos , Fase G1/efectos de los fármacos , Ratones , Datos de Secuencia Molecular , Morfogénesis , Proteínas/farmacología , Receptor Notch1RESUMEN
The current structural model of the B cell antigen receptor (BCR) describes it as a symmetric protein complex in which one membrane-bound immunoglobulin molecule (mIg) is noncovalently bound on each side by an Ig-alpha/Ig-beta heterodimer. Using peptide-tagged Ig-alpha proteins, blue native polyacrylamide gel electrophoresis (BN-PAGE), and biosynthetical labeling of B cells, we find that the mIg:Ig-alpha/Ig-beta complex has a stoichiometry of 1:1 and not 1:2. An anti-Flag stimulation of B cells coexpressing Flag-tagged and wild-type Ig-alpha proteins results in the phosphorylation of both Ig-alpha proteins, suggesting that on the surface of living B cells, several BCR monomers are in contact with each other. A BN-PAGE analysis after limited detergent lysis provides further evidence for an oligomeric BCR structure.
Asunto(s)
Antígenos CD/inmunología , Receptores de Antígenos de Linfocitos B/inmunología , Animales , Antígenos CD/genética , Antígenos CD79 , Línea Celular , Digitonina , Electroforesis en Gel de Poliacrilamida/métodos , Inmunoglobulina D/inmunología , Inmunoglobulina M/inmunología , Indicadores y Reactivos , Ratones , Fosforilación , Receptores de Antígenos de Linfocitos B/genética , SolubilidadRESUMEN
The B cell antigen receptor (BCR) comprises the membrane-bound immunoglobulin (mIg) molecule and the Ig-alpha/Ig-beta heterodimer. By comparing the stability of the IgD-BCR and IgM-BCR in different detergent lysates, we find that the IgD-BCR is more stable than the IgM-BCR. Analysis of chimeric mIgD molecules suggests that the deltam transmembrane region is responsible for the more stable association of mIgD with the Ig-alpha/Ig-beta heterodimer. Further, the differential glycosylation of Ig-alpha molecules, in the two different BCR complexes, is determined solely by the ectodomains of the mIg molecules. The implications of these findings for the intracellular transport and the signalling capacity of the BCRs are discussed.
Asunto(s)
Receptores de Antígenos de Linfocitos B/inmunología , Secuencia de Aminoácidos , Antígenos CD , Antígenos CD79 , Dimerización , Glicosilación , Inmunoglobulina D , Inmunoglobulina M , Datos de Secuencia Molecular , Procesamiento Proteico-PostraduccionalRESUMEN
The B cell antigen receptor (BCR) is a multiprotein complex consisting of the membrane-bound Ig molecule and the Ig-alpha/Ig-beta heterodimer. On BCR engagement, Ig-alpha and Ig-beta become phosphorylated not only on tyrosine residues of the immunoreceptor tyrosine-based activation motif but also on serine and threonine residues. We have mutated all serine and threonine residues in the Ig-alpha tail to alanine and valine, respectively. The mutated Ig-alpha sequence was expressed either as a single-chain Fv/Ig-alpha molecule or in the context of the complete BCR. In both cases, the mutated Ig-alpha showed a stronger tyrosine phosphorylation than the wild-type Ig-alpha and initiated increased signaling on stimulation. These findings suggest that serine/threonine kinases can negatively regulate signal transduction from the BCR.
Asunto(s)
Antígenos CD/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Receptores de Antígenos de Linfocitos B/metabolismo , Serina/metabolismo , Transducción de Señal , Treonina/metabolismo , Tirosina/metabolismo , Proteínas Adaptadoras Transductoras de Señales , Secuencia de Aminoácidos , Antígenos CD/genética , Antígenos CD79 , Proteínas Portadoras/metabolismo , Citoplasma/metabolismo , Inhibidores Enzimáticos/farmacología , Humanos , Fragmentos de Inmunoglobulinas/genética , Fragmentos de Inmunoglobulinas/metabolismo , Región Variable de Inmunoglobulina/genética , Región Variable de Inmunoglobulina/metabolismo , Datos de Secuencia Molecular , Fosfoproteínas/metabolismo , Proteínas Tirosina Fosfatasas/farmacología , Receptores de Antígenos de Linfocitos B/genética , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Serina/genética , Treonina/genética , Células Tumorales Cultivadas , Vanadatos/farmacologíaRESUMEN
During signal transduction through the B cell antigen receptor (BCR), several signaling elements are brought together by the adaptor protein SLP-65. We have investigated the role of SLP-65 in B cell maturation and function in mice deficient for SLP-65. While the mice are viable, B cell development is affected at several stages. SLP-65-deficient mice show increased proportions of pre-B cells in the bone marrow and immature B cells in peripheral lymphoid organs. B1 B cells are lacking. The mice show lower IgM and IgG3 serum titers and poor IgM but normal IgG immune responses. Mutant B cells show reduced Ca2+ mobilization and reduced proliferative responses to B cell mitogens. We conclude that while playing an important role, SLP-65 is not always required for signaling from the BCR.
Asunto(s)
Linfocitos B/patología , Proteínas Portadoras/fisiología , Síndromes de Inmunodeficiencia/genética , Activación de Linfocitos/fisiología , Fosfoproteínas , Procesamiento Proteico-Postraduccional/inmunología , Receptores de Antígenos de Linfocitos B/inmunología , Transducción de Señal/inmunología , Proteínas Adaptadoras Transductoras de Señales , Animales , Formación de Anticuerpos , Subgrupos de Linfocitos B , Linfocitos B/inmunología , Médula Ósea/patología , Señalización del Calcio , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Diferenciación Celular , Células Cultivadas , Citometría de Flujo , Recuento de Linfocitos , Tejido Linfoide/patología , Ratones , Ratones Noqueados , Mitógenos/farmacología , Fosforilación , Proteínas Tirosina Quinasas/metabolismoRESUMEN
Activation of lymphocytes through their antigen receptors leads to mobilization of intracellular Ca(2+) ions. This process requires expression of SLP adaptors and involves phosphorylation of phospholipase C-gamma isoforms by the Tec-related protein tyrosine kinase Btk in B cells and Itk in T cells. The SH2 domain of Btk and Itk is essential for phospholipase C-gamma phosphorylation and mutations in this domain lead to the X-linked agammaglobulinemia immuno deficiency in humans. Here we show that, in contrast to SH2 domains from other signaling proteins, the Btk and Itk SH2 domains exhibit a restricted binding specificity. They bind selectively to tyrosine-phosphorylated SLP-65 and SLP-76 in activated B and T cells, respectively. Our findings suggest that Btk/Itk and phospholipase C-gamma both bind via their SH2 domain to phosphorylated SLP adaptors, and that this association is required for the activation of phospholipase C-gamma.
Asunto(s)
Linfocitos B/metabolismo , Proteínas Portadoras , Fosfoproteínas/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Proteínas Tirosina Quinasas Receptoras/metabolismo , Receptores de Antígenos de Linfocitos B/metabolismo , Transducción de Señal , Dominios Homologos src , Proteínas Adaptadoras Transductoras de Señales , Agammaglobulinemia Tirosina Quinasa , Línea Celular , Glutatión Transferasa/metabolismo , Humanos , Células Jurkat , Fosfoproteínas/aislamiento & purificación , Fosforilación , Proteínas Tirosina Quinasas/aislamiento & purificación , Receptores Inmunológicos , Proteínas Recombinantes de Fusión/metabolismo , Tirosina/metabolismoRESUMEN
The identification of substrates for protein tyrosine kinases in B cells is a critical step to a better understanding of the molecular mechanism(s) of lymphocyte activation through the antigen receptor. The substrate proteins were immunopurified from stimulated B cells and separated by two-dimensional gel electrophoresis techniques using either the isoelectric focussing (IEF)/SDS-PAGE or the non-equilibrium PH gradient electrophoresis (NEPHGE)/SDS-PAGE method. The biochemical characteristics of the proteins (isoelectric point and relative molecular mass) obtained and the subsequent use of antibodies that are specific for different cellular proteins confirmed the participation of HS1, Vav, Ig-alpha, Lyn and Btk in antigen receptor-mediated signal transduction. The heat shock cognate protein HSC70 was identified as a novel substrate protein in activated B cells. An important signaling function has previously been suggested for a 65-kDa protein (p65), whose phosphorylation can be detected before that of other substrate proteins. The analysis identified p65 as a so far unknown protein. Based on p65 peptide sequences, the full length cDNA was isolated and found to encode a B cell-specific adaptor protein, called SLP-65.